Jean Trédaniel

7.4k total citations
109 papers, 2.6k citations indexed

About

Jean Trédaniel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jean Trédaniel has authored 109 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Jean Trédaniel's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (20 papers). Jean Trédaniel is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (20 papers). Jean Trédaniel collaborates with scholars based in France, Italy and Switzerland. Jean Trédaniel's co-authors include Paolo Boffetta, Albert Hirsch, Gérard Zalcman, Rodolfo Saracci, Richard Lubin, Thierry Soussi, A Hirsch, Eva Buiatti, Antonio Greco and Patricia Forgez and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Environmental Health Perspectives.

In The Last Decade

Jean Trédaniel

100 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jean Trédaniel 1.2k 974 565 428 288 109 2.6k
Brendan Doyle 1.1k 0.9× 638 0.7× 1.5k 2.6× 649 1.5× 165 0.6× 56 3.5k
Diego Cortinovis 2.2k 1.8× 1.5k 1.5× 605 1.1× 344 0.8× 167 0.6× 181 3.4k
Thierry Jahan 1.8k 1.4× 1.8k 1.8× 680 1.2× 203 0.5× 215 0.7× 79 3.5k
Hiroji Uemura 696 0.6× 1.2k 1.3× 616 1.1× 625 1.5× 276 1.0× 232 2.7k
Nachimuthu Natarajan 749 0.6× 826 0.8× 528 0.9× 374 0.9× 138 0.5× 58 2.6k
John Hilton 1.2k 1.0× 616 0.6× 828 1.5× 182 0.4× 300 1.0× 162 2.6k
Sun Min Lim 1.5k 1.2× 1.6k 1.7× 900 1.6× 216 0.5× 156 0.5× 132 2.8k
Nader Hanna 1.5k 1.2× 736 0.8× 804 1.4× 836 2.0× 161 0.6× 111 3.0k
Guowei Che 1.3k 1.1× 1.7k 1.8× 664 1.2× 1.1k 2.5× 214 0.7× 249 3.8k
Shigemitsu Takashima 1.6k 1.3× 1.1k 1.1× 435 0.8× 497 1.2× 640 2.2× 158 3.4k

Countries citing papers authored by Jean Trédaniel

Since Specialization
Citations

This map shows the geographic impact of Jean Trédaniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Trédaniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Trédaniel more than expected).

Fields of papers citing papers by Jean Trédaniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Trédaniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Trédaniel. The network helps show where Jean Trédaniel may publish in the future.

Co-authorship network of co-authors of Jean Trédaniel

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Trédaniel. A scholar is included among the top collaborators of Jean Trédaniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Trédaniel. Jean Trédaniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordina‐Duverger, Emilie, Diane P. Martin, Jean Trédaniel, et al.. (2022). Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study). International Journal of Environmental Research and Public Health. 19(23). 16246–16246. 14 indexed citations
2.
Gounant, V., M. Duruisseaux, Olivier Bylicki, et al.. (2021). Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers. 13(5). 1040–1040. 9 indexed citations
3.
Martin, Diane P., Sylvie Cénée, Martine Antoine, et al.. (2021). Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study). BMC Cancer. 21(1). 711–711. 10 indexed citations
4.
Yannoutsos, Alexandra, Gilles Châtellier, Diane Damotte, et al.. (2021). Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature. JMV-Journal de Médecine Vasculaire. 46(2). 53–65. 7 indexed citations
5.
Costantini, Adrien, Vincent Fallet, Jennifer Corny, et al.. (2019). Nivolumab-refractory patients with advanced non-small-cell lung cancer. Lung Cancer. 130. 128–134. 15 indexed citations
6.
Costantini, Adrien, Jennifer Corny, Vincent Fallet, et al.. (2018). Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer. ERJ Open Research. 4(2). 120–2017. 22 indexed citations
7.
8.
Westeel, Virginie, Fabrice Barlési, J.J. Lafitte, et al.. (2017). Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC). Annals of Oncology. 28. v452–v452. 25 indexed citations
9.
Blay, Jean‐Yves, Julien Mazières, David Pérol, et al.. (2016). Vemurafenib (VM) in non-melanoma V600 and non-V600 BRAF mutated cancers: first results of the ACSE trial. Annals of Oncology. 27. vi16–vi16. 3 indexed citations
10.
Revel, Marie‐Pierre, M.F. Carette, Maties Torrent, & Jean Trédaniel. (2014). Diagnosis and standardized report for non-small cell lung cancer. Diagnostic and Interventional Imaging. 95(7-8). 727–738. 6 indexed citations
11.
Massard, Christophe, Vincent Haddad, Jean‐Pierre Pignon, et al.. (2009). Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice. Journal of Thoracic Oncology. 4(12). 1504–1510. 13 indexed citations
12.
Planchard, David, Julien Dômont, E. Taranchon, et al.. (2009). The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma. Annals of Oncology. 20(7). 1257–1263. 16 indexed citations
13.
Trédaniel, Jean, Jean‐Yves Blay, François Goldwasser, et al.. (2005). Decision making process in oncology practice: Is the information available and what should it consist of?. Critical Reviews in Oncology/Hematology. 54(3). 165–170. 4 indexed citations
14.
Gervais, R., A Ducoloné, Jean-Luc Breton, et al.. (2004). Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 16(1). 90–96. 104 indexed citations
15.
Boffetta, Paolo, Jean Trédaniel, & Antonio Greco. (2000). Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis.. Environmental Health Perspectives. 108(1). 73–82. 141 indexed citations
16.
Trédaniel, Jean, Paolo Boffetta, Claude Chastang, & A Hirsch. (1995). Clinico-pathological features and survival of lung cancer patients in Paris, France. European Journal of Cancer. 31(13-14). 2296–2301. 4 indexed citations
17.
Trédaniel, Jean, Paolo Boffetta, & Alexander W. Hirsch. (1994). Faut-il reconnaître que le tabagisme passif est cancérogène?. Revue des Maladies Respiratoires. 11(5). 1 indexed citations
18.
Trédaniel, Jean, et al.. (1994). Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatric and Perinatal Epidemiology. 8(3). 233–255. 36 indexed citations
19.
Schlichtholz, Beata, Jean Trédaniel, Richard Lubin, et al.. (1994). Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. British Journal of Cancer. 69(5). 809–816. 128 indexed citations
20.
Trédaniel, Jean, Pauline Brice, Éric Lepage, et al.. (1992). The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas. European Respiratory Journal. 5(2). 170–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brendan Doyle Breakdown of academic impact, for papers by Diego Cortinovis Breakdown of academic impact, for papers by Thierry Jahan Breakdown of academic impact, for papers by Hiroji Uemura Breakdown of academic impact, for papers by Nachimuthu Natarajan Breakdown of academic impact, for papers by John Hilton Breakdown of academic impact, for papers by Sun Min Lim Breakdown of academic impact, for papers by Nader Hanna Breakdown of academic impact, for papers by Guowei Che Breakdown of academic impact, for papers by Shigemitsu Takashima
Rankless by CCL
2026